Juniper

What Is Juniper?

Juniper is a common conifer species that can be found all over North America, Europe, and Asia. It has been a particularly successful species worldwide for its ability to thrive in both hot and cold, wet and dry, and sunny or shaded areas.

The berries are used as a medicine and have a distinctive pine fragrance and flavor. Juniper berries are high in many of the same volatile compounds that can be found in the pine tree and other conifers, and share a similar antimicrobial profile as well.

Juniper is mainly used as a traditional urinary antiseptic and for its antimicrobial actions.

New research is suggesting junipers use as a nootropic to enhance memory.

What Is Juniper Used For?

The berries of juniper are high in antiseptic volatile oils, which makes it useful for microbial infection including topical and upper respiratory tract infections. It’s also a popular traditional urinary antiseptic and diuretic for treating lower urinary tract infections — though the antiseptic reputation is well established in tradition, proven efficacy against clinical UTIs has not been demonstrated in humans.

Newer use involves junipers anti-acetylcholinesterase activity for enhancing memory.

Traditional Uses

The British herbal pharmacopeia lists juniper as a diuretic, antiseptic, carminative, stomachic, and anti-rheumatic useful for acute or chronic cystitis, flatulent colic, edema, and rheumatism. It’s listed as a topical application for rheumatic pain in the joints and muscles ^{22Reference 22British Herbal Medicine Association · 1983British Herbal Pharmacopoeia}.

It was frequently burned by the ancient Greeks to combat epidemics and was used by both the native Tibetans and Native Americans for ceremonial purposes ^{21Reference 21Battaglia · 2003The complete guide to aromatherapy (2nd ed.)}.

Juniper is also a popular addition to cooking, especially game meat and fish.

Juniper berries and the essential oils are popular in the perfume, aromatherapy, food, and liquor industries ^{23Reference 23Damjanović et al. · 2003A comparison between the oil, hexane extract and supercritical carbon dioxide extract of Juniperus communis LView study →}.

Botanical Information

Juniperus is a genus of conifers, containing between 50 and 67 species. It’s a member of the Cupressaceae family or “cypress family” of plants. This family comprises 27-30 genera of mainly monoecious trees and shrubs. The other principal medicinal members of this family is Thuja spp. (incense cedar).

Juniper has a small (5-8mm) fruit with a smooth, dark purple colored, waxy shell. The taste resembles pine and has sweet overtones ^{22Reference 22British Herbal Medicine Association · 1983British Herbal Pharmacopoeia}.

It can grow up to 12 m tall but is generally much smaller. The berries take roughly 3 years to mature ^{21Reference 21Battaglia · 2003The complete guide to aromatherapy (2nd ed.)}.

Habitat, Ecology & Distribution

Juniper is native to Europe, Asia, and North America ^{22Reference 22British Herbal Medicine Association · 1983British Herbal Pharmacopoeia}.

The best Juniper is suggested to come from northern Italy, Austria, Czech Republic, Hungary, Croatia, Serbia, and France ^{21Reference 21Battaglia · 2003The complete guide to aromatherapy (2nd ed.)}.

Harvesting, Collection & Preparation

When extracting juniper berry, hexane was found to yield a higher amount than both super critical carbon dioxide, and hydrodistillation ^{23Reference 23Damjanović et al. · 2003A comparison between the oil, hexane extract and supercritical carbon dioxide extract of Juniperus communis LView study →}.

If terpene hydrocarbons are desired, extraction by hydrodistillation is best. If the resin is desired (including long-chain paraffinic acids, and hexadecanoic acid) then the hexane or supercritical CO2 is the best extraction method. These methods will also produce a more stable extract. If terpinen-4-ol is desired (diuretic), supercritical CO2 extraction is the best ^{23Reference 23Damjanović et al. · 2003A comparison between the oil, hexane extract and supercritical carbon dioxide extract of Juniperus communis LView study →}.

Phytochemistry

Juniper berry is first and foremost an essential-oil drug: the volatile oil is a mixture of monoterpene terpene hydrocarbons dominated by Alpha-pinene, typically the largest single component at roughly 30–50% of the oil, with Beta-pinene (~5–18%), Myrcene (~3–25%), Sabinene (~5–17%) and Limonene (~1–14%) making up most of the remainder. These pine-scented monoterpenes carry the berry’s antimicrobial and carminative character ^{1,23Reference 1Höferl et al. · 2016In vitroChemical composition and antioxidant properties of juniper berry (Juniperus communis L.) essential oil — in vitroView study →Reference 23Damjanović et al. · 2003A comparison between the oil, hexane extract and supercritical carbon dioxide extract of Juniperus communis LView study →}.

The diuretic and urinary-antiseptic reputation rests largely on terpinen-4-ol, a minor but pharmacologically important oxygenated monoterpene (trace up to ~6% of the oil) best recovered by supercritical-CO₂ extraction. A separate, less volatile resin fraction holds long-chain paraffinic acids and the fatty acid hexadecanoic acid (palmitic acid); these are the components favoured by hexane or CO₂ extraction over hydrodistillation ^{23Reference 23Damjanović et al. · 2003A comparison between the oil, hexane extract and supercritical carbon dioxide extract of Juniperus communis LView study →}.

Beyond the oil, the berry and needle carry a polyphenol fraction that drives much of the antioxidant and anti-inflammatory activity — the flavonols quercetin, hyperoside and rutin, the flavanonol taxifolin and the organic acid quinic acid, enriched in ethyl-acetate and butanol fractions rather than in the essential oil ^{2,7Reference 2Jojić et al. · 2026In vitroFraction-dependent polyphenolic profile and biological activities of Juniperus communis pseudo-fruit extracts: antioxidant, antimicrobial and selective antimelanoma effects — in vitroView study →Reference 7Bolunduț et al. · 2026AnimalJuniperus communis L. needle extract modulates oxidative and inflammatory pathways in an experimental model of acute inflammation — animal modelView study →}.

Constituent Summary

Percentages are share of the berry essential oil and vary widely with ripeness, provenance and extraction method; polyphenols and resin acids are not part of the oil and are given as No Data.

Pharmacology & Research

The published pharmacology of common juniper (Juniperus communis) is sizeable but sits almost entirely in the preclinical tier: dozens of in vitro assays on the berry essential oil and polyphenol-rich extracts, a smaller set of rodent studies, and no completed human efficacy trial for any medicinal indication. The best-replicated activities are antioxidant and antimicrobial — both consistent across independent labs and both matching the berry’s traditional roles as a urinary antiseptic and preservative. The most active emerging signals are anti-inflammatory and anticancer, each now supported by in vivo rodent work as well as cell-line data, while the page’s headline “nootropic” claim rests on a single lab’s inhaled-oil model in amyloid-injected rats. Throughout, extract type is decisive: monoterpene-rich essential oil, whole decoction, and ethyl-acetate polyphenol fractions behave differently, and results from one rarely transfer to another. Read the scores below as a rank of preclinical evidence weight, not as clinical proof.

0. Evidence by indication

Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric, and I’ll keep honing the formula over time. Each indication name links down to its write-up.

Indication	Support	Rests on
Antioxidant	███████░░░ 72%	Consistent in vitro scavenging + two rat models; no human data. Oil and polyphenol fractions both active.
Antimicrobial	███████░░░ 68%	Well-replicated in vitro MICs; strongest antifungal. Matches actual use; all cell-based, no clinical.
Anti-inflammatory	██████░░░░ 64%	Several rat paw-edema / turpentine / LPS models; NF-κB mapped. Preclinical only.
Hepatoprotective	██████░░░░ 56%	One rat paracetamol model + antioxidant mechanism; leaf fraction, not berry.
Anticancer	█████░░░░░ 52%	Multiple cell lines + two rodent studies; extract doses unlike culinary/tea use.
Antidiabetic	█████░░░░░ 50%	Single robust in vivo decoction study in diabetic rats; drinkable prep, but not replicated.
Nootropic (anti-AChE)	█████░░░░░ 46%	One lab’s inhaled-oil rat amyloid model + in vitro AChE inhibition. Aromatherapy prep, not the berry.
Diuretic	████░░░░░░ 38%	Core traditional use; terpinen-4-ol aquaretic mechanism; essentially no modern human data.

1. Antioxidant

This is juniper’s most consistently documented activity. Berry essential oil from independent samples scavenges DPPH, ABTS, hydroxyl and superoxide radicals and chelates iron in vitro, with α-pinene-dominated oils showing strong electron-transfer antioxidant capacity though weaker lipid-peroxidation inhibition than the reference butylated hydroxytoluene (BHT) ^{1Reference 1Höferl et al. · 2016In vitroChemical composition and antioxidant properties of juniper berry (Juniperus communis L.) essential oil — in vitroView study →}. Polyphenol-rich fractions — driven by quercetin, hyperoside and rutin rather than the oil — carry the strongest radical-scavenging, and the ethyl-acetate fraction of the pseudo-fruit reaches the highest phenolic content and activity ^{2,3Reference 2Jojić et al. · 2026In vitroFraction-dependent polyphenolic profile and biological activities of Juniperus communis pseudo-fruit extracts: antioxidant, antimicrobial and selective antimelanoma effects — in vitroView study →Reference 3Öztürk et al. · 2011In vitroEvaluation of fruit extracts of six Turkish Juniperus species for their antioxidant, anticholinesterase and antimicrobial activities — in vitroView study →}. The effect also appears in vivo: juniper oil restored superoxide dismutase, glutathione peroxidase and catalase in the hearts of cholesterol-fed rats ^{6Reference 6Gumral et al. · 2015AnimalJuniperus communis Linn oil decreases oxidative stress and increases antioxidant enzymes in the heart of rats administered a cholesterol-rich diet — animal modelView study →}, and a needle extract lowered malondialdehyde, protein-oxidation and DNA-oxidation markers in acutely inflamed rats ^{7Reference 7Bolunduț et al. · 2026AnimalJuniperus communis L. needle extract modulates oxidative and inflammatory pathways in an experimental model of acute inflammation — animal modelView study →}.

Gap: every result is in vitro or in animals — no human antioxidant biomarker study exists, and the “which fraction” answer (oil vs. polyphenols) changes the active molecules entirely.

2. Antimicrobial

The berry oil shows broad but moderate activity. Against a panel of sixteen bacteria, ten yeasts and dermatophytes, juniper berry oil was similarly bactericidal to Gram-positive and Gram-negative species (MIC 8–70% v/v) but markedly more potent as a fungicide, with the strongest activity against Candida species and dermatophytes (MIC 0.39–2% v/v) ^{9Reference 9Pepeljnjak et al. · 2006In vitroAntimicrobial activity of juniper berry essential oil (Juniperus communis L., Cupressaceae) — in vitroView study →}. Solvent fractions of the pseudo-fruit add weak-to-moderate antibacterial activity, notably against Streptococcus pyogenes ^{2Reference 2Jojić et al. · 2026In vitroFraction-dependent polyphenolic profile and biological activities of Juniperus communis pseudo-fruit extracts: antioxidant, antimicrobial and selective antimelanoma effects — in vitroView study →}, and reviews consistently list antibacterial, antifungal and antiviral activity as the berry’s best-characterised antimicrobial profile ^{18,19Reference 18Raina et al. · 2019ReviewPotential of Juniperus communis L as a nutraceutical in human and veterinary medicine — reviewView study →Reference 19Gonçalves et al. · 2022ReviewZimbro (Juniperus communis L.) as a promising source of bioactive compounds and biomedical activities — reviewView study →}. The activity tracks the monoterpene content — alpha-pinene, sabinene and terpinen-4-ol — which aligns mechanistically with the traditional use as a topical and urinary antiseptic.

Gap: all data are in vitro MICs; the concentrations that inhibit microbes in a dish are far above what a diuretic dose or culinary use delivers to urine or tissue, and there is no clinical infection study.

3. Anti-inflammatory

Rodent models give this indication genuine in vivo support. A hydroalcoholic berry extract reduced dextran- and kaolin-induced paw edema in rats, with diclofenac sodium as the reference drug ^{5Reference 5Fierașcu et al. · 2018AnimalGenoprotective, antioxidant, antifungal and anti-inflammatory evaluation of hydroalcoholic extract of wild-growing Juniperus communis L. — animal modelView study →}; a comparative screen of five Juniperus taxa also found the methanolic fruit and leaf extracts of J. communis var. saxatilis among the more active in carrageenan-induced edema ^{16Reference 16Akkol et al. · 2009AnimalA comparative study on the antinociceptive and anti-inflammatory activities of five Juniperus taxa — animal modelView study →}. An ethanolic needle extract attenuated turpentine-oil-induced acute inflammation while lowering NF-κB activity ^{7Reference 7Bolunduț et al. · 2026AnimalJuniperus communis L. needle extract modulates oxidative and inflammatory pathways in an experimental model of acute inflammation — animal modelView study →}. Mechanistically the clearest signal comes from an LPS-induced acute kidney injury model, where J. communis extract suppressed NF-κB signalling and activated the AMPK and Nrf2/HO-1 pathways, cutting tumour-necrosis-factor-α and interleukin-1β release ^{8Reference 8Lin et al. · 2024AnimalJuniperus communis extract ameliorates lipopolysaccharide-induced acute kidney injury through the AMPK pathway — animal modelView study →}. These converge on NF-κB downregulation as the shared driver of the antioxidant and anti-inflammatory effects.

Gap: consistent across rat models but entirely preclinical; extract types differ between studies (berry vs. needle), and no dose-ranging or human data exist.

4. Hepatoprotective

A phenol-rich ethyl-acetate fraction of J. communis leaves protected rat livers against paracetamol-induced damage, lowering serum aspartate and alanine aminotransferases, total and direct bilirubin, alongside strong DPPH scavenging (IC50 177 µg/mL) and iron chelation ^{4Reference 4Ved et al. · 2020AnimalAntioxidant and hepatoprotective potential of phenol-rich fraction of Juniperus communis Linn. leaves — animal modelView study →}. The effect is plausibly downstream of the same antioxidant / NF-κB mechanism, and antitumour work in hepatocellular carcinoma cells is consistent with a hepatic tropism for the extract ^{10Reference 10Huang et al. · 2022In vitroEvaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo — animal modelView study →}.

Gap: rests on a single in vivo model using a leaf fraction — not the berry the herb is actually used as — so the finding does not transfer cleanly to juniper-berry preparations.

5. Anticancer

This is preclinical but unusually well-replicated across models. Berry and whole-plant extracts induce G0/G1 or S-phase arrest and intrinsic-pathway apoptosis — elevated Bax/Bcl-2 ratio, cleaved caspase-3, cytochrome-c release — in hepatocellular carcinoma, cervical (HeLa) and colorectal (HCT 116) cells ^{10,12Reference 10Huang et al. · 2022In vitroEvaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo — animal modelView study →Reference 12Marković et al. · 2024In vitroInsights into molecular mechanisms of anticancer activity of Juniperus communis essential oil in HeLa and HCT 116 cells — in vitroView study →}. Two rodent studies extend this in vivo: a berry extract suppressed hepatocellular carcinoma growth and extended survival with low toxicity ^{10Reference 10Huang et al. · 2022In vitroEvaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo — animal modelView study →}, and a berry extract crossed the blood-brain barrier to slow rat glioblastoma with selectivity over normal cells ^{11Reference 11Tsai et al. · 2018AnimalJuniperus communis extract exerts antitumor effects in human glioblastomas through the blood-brain barrier — animal modelView study →}. The oil and post-distillation waste also synergise with doxorubicin against lung carcinoma cells ^{13Reference 13Vasilijević et al. · 2018In vitroChemical characterization, antioxidant, genotoxic and in vitro cytotoxic activity assessment of Juniperus communis var. saxatilis — in vitroView study →}, and the ethyl-acetate fraction is selectively cytotoxic to melanoma over keratinocytes ^{2Reference 2Jojić et al. · 2026In vitroFraction-dependent polyphenolic profile and biological activities of Juniperus communis pseudo-fruit extracts: antioxidant, antimicrobial and selective antimelanoma effects — in vitroView study →}.

Gap: no human data, and the active concentrations require concentrated extracts far beyond culinary or tea exposure — this is a drug-discovery lead, not a claim for eating juniper berries.

6. Antidiabetic

A decoction of juniper berries lowered blood glucose in both normoglycaemic and streptozotocin-diabetic rats, and over 24 days of dosing reduced blood glucose, mortality and weight loss in diabetic animals — effects the authors attributed to increased peripheral glucose consumption and potentiated glucose-induced insulin secretion ^{14Reference 14Sánchez de Medina et al. · 1994AnimalHypoglycemic activity of juniper “berries” — animal modelView study →}. Reviews list hypoglycaemic and hypolipidaemic effects among the berry’s documented experimental activities ^{18,19Reference 18Raina et al. · 2019ReviewPotential of Juniperus communis L as a nutraceutical in human and veterinary medicine — reviewView study →Reference 19Gonçalves et al. · 2022ReviewZimbro (Juniperus communis L.) as a promising source of bioactive compounds and biomedical activities — reviewView study →}.

Gap: the core evidence is a single 1994 in vivo study; it has not been independently replicated, and there is no human glycaemic trial. The redeeming feature is that the active preparation — a water decoction — matches how the berry is realistically consumed.

7. Nootropic (anti-AChE)

This is the page’s “new use” and the thinnest of the scored indications. Inhaled J. communis volatile oil (1–3%, 60 min daily for 21 days) reduced acetylcholinesterase activity and oxidative damage in the hippocampus of rats given intracerebroventricular amyloid-beta (1–42), improving memory measures in a dose-dependent way ^{15Reference 15Cioancă et al. · 2016AnimalAnti-acetylcholinesterase and antioxidant activities of inhaled juniper oil on amyloid beta (1-42)-induced oxidative stress in the rat hippocampus — animal modelView study →}. In vitro, fruit extracts of Turkish Juniperus species including J. communis show anticholinesterase activity ^{3Reference 3Öztürk et al. · 2011In vitroEvaluation of fruit extracts of six Turkish Juniperus species for their antioxidant, anticholinesterase and antimicrobial activities — in vitroView study →}. The mechanism — cholinesterase inhibition plus antioxidant protection of the hippocampus — is coherent, but the in vivo evidence is from a single research group.

Gap: the active preparation is inhaled essential oil (aromatherapy), not the ingested berry; there is no human cognitive data, and single-lab in vivo findings need independent replication before the “memory herb” framing is warranted.

8. Diuretic

Diuresis is juniper’s oldest documented action and the basis of its “urinary antiseptic” reputation, attributed chiefly to terpinen-4-ol, an oxygenated monoterpene that acts as an aquaretic by increasing glomerular filtration rather than by irritating the tubules. An isolated diuretic principle was described in the mid-twentieth-century literature ^{17Reference 17Janků et al. · 1957Diuretic substance from juniper (Juniperus communis L.)View study →}, and reviews continue to list diuretic activity as a defining property of the berry ^{18Reference 18Raina et al. · 2019ReviewPotential of Juniperus communis L as a nutraceutical in human and veterinary medicine — reviewView study →}. Importantly, the modern reading is that pure J. communis oil — low in the harsher components once blamed for kidney irritation — drives water loss through terpinen-4-ol without the nephrotoxicity historically ascribed to adulterated or whole-oil preparations; a regulatory safety review of Juniperus extracts likewise found the fragrance-grade materials acceptable for topical use while noting no assessment of therapeutic oral dosing ^{20Reference 20CIR Expert Panel · 2001ReviewFinal report on the safety assessment of Juniperus communis extract, J. oxycedrus extract/tar, J. phoenicea extract, and J. virginiana extract — safety reviewView study →}.

Gap: despite being the herb’s signature use, there is essentially no modern controlled human diuresis study; the mechanism is well-reasoned but the human dose-response is undocumented.

Mechanisms

Mechanism	Drives	Key compounds
Radical scavenging + metal chelation; SOD/GSH-Px/CAT restoration	antioxidant, hepatoprotective, cardioprotective	alpha-pinene, quercetin, hyperoside
NF-κB ↓, AMPK ↑, Nrf2/HO-1 ↑	anti-inflammatory, hepatoprotective	polyphenol fraction, terpinen-4-ol
Intrinsic apoptosis (Bax/Bcl-2 ↑, caspase-3 ↑), cell-cycle arrest, MMP2/9 ↓	anticancer	berry essential oil, ethyl-acetate polyphenols
Acetylcholinesterase inhibition + hippocampal antioxidant protection	nootropic (anti-AChE)	volatile oil (inhaled)
Aquaretic ↑ glomerular filtration	diuretic, urinary antiseptic	terpinen-4-ol
Membrane disruption of microbes/fungi	antimicrobial	sabinene, alpha-pinene, terpinen-4-ol

Clinical trials

No registered clinical trials of Juniperus communis for any medicinal indication were identified — the only ClinicalTrials.gov records naming a juniper concern Juniperus oxycedrus pollen-allergen immunotherapy and unrelated protocols, not therapeutic use of the berry. The evidence base is preclinical.

Completed	Planned	Terminated	Preclinical
0	0	0	~40+

Last checked: July 2026.

Dosage

In research, juniper is almost never given as a standardised human dose — the evidence base is preclinical, and the studies that report a dose use rodent preparations (berry decoction, berry oil, or inhaled oil) that do not convert cleanly to a whole-herb amount.

Indication	Preparation	Dose	Est. dried-herb equivalent	Source
Antidiabetic	Aqueous berry decoction (rat)	125–250 mg berries/kg	~9–17 g/day for 70 kg (direct berry weight, allometry not applied)	14Reference 14Sánchez de Medina et al. · 1994AnimalHypoglycemic activity of juniper “berries” — animal modelView study →
Antioxidant (cardiac)	Berry oil in rats	50–200 mg/kg oil	oil, not whole herb — no berry equivalent	6Reference 6Gumral et al. · 2015AnimalJuniperus communis Linn oil decreases oxidative stress and increases antioxidant enzymes in the heart of rats administered a cholesterol-rich diet — animal modelView study →
Nootropic (anti-AChE)	Inhaled volatile oil (rat)	1–3% oil, 60 min/day	inhalation — no oral equivalent	15Reference 15Cioancă et al. · 2016AnimalAnti-acetylcholinesterase and antioxidant activities of inhaled juniper oil on amyloid beta (1-42)-induced oxidative stress in the rat hippocampus — animal modelView study →

The antidiabetic row is a direct berry-decoction weight, so no marker back-conversion is applied; the human figure is an unadjusted mg/kg scale-up shown only for order of magnitude, not a recommended dose. The oil and inhalation rows have no meaningful whole-herb equivalent and are marked so.

Traditional Dosage

Western herbal practice uses the whole berry as a short-course diuretic and carminative, dosed by liquid extract, infusion or tincture rather than to a chemical marker.

System	Preparation	Dose
Western herbal (BHP)	1:2 liquid extract	10–20 mL (weekly range per BHP)
Western herbal (BHP)	Dried berries / infusion	~2–4 g dried berries, short courses
Western herbal	Tincture 1:5 (45%)	traditional range per herbal texts

Safety

Juniper berry is classed as moderately toxic and is best reserved for short courses. The essential oil and whole-berry preparations are irritant in excess, and the herb’s traditional caution against use in kidney disease persists — though modern analysis attributes the historic “renal irritation” to whole/adulterated oils rather than to pure oil, whose diuretic action runs through terpinen-4-ol and increased glomerular filtration rather than tubular damage ^{17Reference 17Janků et al. · 1957Diuretic substance from juniper (Juniperus communis L.)View study →}. Antimicrobial and antioxidant activity is well documented in vitro ^{1,9Reference 1Höferl et al. · 2016In vitroChemical composition and antioxidant properties of juniper berry (Juniperus communis L.) essential oil — in vitroView study →Reference 9Pepeljnjak et al. · 2006In vitroAntimicrobial activity of juniper berry essential oil (Juniperus communis L., Cupressaceae) — in vitroView study →}, but no human safety or interaction study exists, so drug-interaction risk is uncharacterised rather than established as low. A regulatory safety review of Juniperus extracts found the fragrance-grade materials acceptable for topical cosmetic use but did not assess therapeutic oral dosing ^{20Reference 20CIR Expert Panel · 2001ReviewFinal report on the safety assessment of Juniperus communis extract, J. oxycedrus extract/tar, J. phoenicea extract, and J. virginiana extract — safety reviewView study →}.

Herb–drug interactions have not been specifically evaluated for juniper; the absence of reported problems should not be read as evidence of safety. Given the documented in vivo hypoglycaemic effect ^{14Reference 14Sánchez de Medina et al. · 1994AnimalHypoglycemic activity of juniper “berries” — animal modelView study →}, a theoretical additive effect with antidiabetic drugs is worth precautionary attention.

Contraindications

• Kidney infection
• Kidney inflammation
• Pregnancy

Pregnancy & lactation

Avoid. Juniper is traditionally contraindicated in pregnancy on the grounds that it may stimulate uterine contractions, and this caution is carried by the pharmacopoeial and herbal literature. No controlled reproductive-toxicity study of J. communis berry in pregnancy or lactation has been performed, so the recommendation rests on traditional contraindication and precaution, not on modern data — do not read the absence of studies as evidence of safety.

Clinical Applications

Juniper has a long traditional reputation as a mild urinary antiseptic and diuretic, and its antimicrobial effects are well characterised in vitro and applied both topically and internally. Its emerging nootropic signal is preclinical and rests on a single research group’s inhaled-oil model, so the “memory herb” framing should be read as a research lead awaiting replication, not an established use. There is no human clinical trial for any juniper indication; the herb’s value here is traditional and mechanistic rather than clinically proven.

References

1. Höferl, M., Stoilova, I., Schmidt, E., et al. (2016). Chemical composition and antioxidant properties of juniper berry (Juniperus communis L.) essential oil — in vitro. Antioxidants (Basel). https://pubmed.ncbi.nlm.nih.gov/26784665/
2. Jojić, A. A., et al. (2026). Fraction-dependent polyphenolic profile and biological activities of Juniperus communis pseudo-fruit extracts: antioxidant, antimicrobial and selective antimelanoma effects — in vitro. Antioxidants (Basel). https://pubmed.ncbi.nlm.nih.gov/42352044/
3. Öztürk, M., Tümen, İ., Uğur, A., et al. (2011). Evaluation of fruit extracts of six Turkish Juniperus species for their antioxidant, anticholinesterase and antimicrobial activities — in vitro. J Sci Food Agric. https://pubmed.ncbi.nlm.nih.gov/21384354/
4. Ved, A., et al. (2020). Antioxidant and hepatoprotective potential of phenol-rich fraction of Juniperus communis Linn. leaves — animal model. Pharmacognosy Magazine. https://pubmed.ncbi.nlm.nih.gov/28216892/
5. Fierașcu, I., et al. (2018). Genoprotective, antioxidant, antifungal and anti-inflammatory evaluation of hydroalcoholic extract of wild-growing Juniperus communis L. — animal model. BMC Complement Altern Med. https://pubmed.ncbi.nlm.nih.gov/29301523/
6. Gumral, N., et al. (2015). Juniperus communis Linn oil decreases oxidative stress and increases antioxidant enzymes in the heart of rats administered a cholesterol-rich diet — animal model. Toxicol Ind Health. https://pubmed.ncbi.nlm.nih.gov/23293127/
7. Bolunduț, D., et al. (2026). Juniperus communis L. needle extract modulates oxidative and inflammatory pathways in an experimental model of acute inflammation — animal model. Molecules. https://pubmed.ncbi.nlm.nih.gov/41599297/
8. Lin, T. C., et al. (2024). Juniperus communis extract ameliorates lipopolysaccharide-induced acute kidney injury through the AMPK pathway — animal model. Food Sci Nutr. https://pubmed.ncbi.nlm.nih.gov/36249972/
9. Pepeljnjak, S., Kosalec, I., Kalođera, Z., Blažević, N. (2006). Antimicrobial activity of juniper berry essential oil (Juniperus communis L., Cupressaceae) — in vitro. Acta Pharm (Zagreb). https://pubmed.ncbi.nlm.nih.gov/16375831/
10. Huang, N. C., et al. (2022). Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo — animal model. Biosci Rep. https://pubmed.ncbi.nlm.nih.gov/34151367/
11. Tsai, N. M., et al. (2018). Juniperus communis extract exerts antitumor effects in human glioblastomas through the blood-brain barrier — animal model. Cell Physiol Biochem. https://pubmed.ncbi.nlm.nih.gov/30261501/
12. Marković, T., et al. (2024). Insights into molecular mechanisms of anticancer activity of Juniperus communis essential oil in HeLa and HCT 116 cells — in vitro. Plants (Basel). https://pubmed.ncbi.nlm.nih.gov/39273835/
13. Vasilijević, B., et al. (2018). Chemical characterization, antioxidant, genotoxic and in vitro cytotoxic activity assessment of Juniperus communis var. saxatilis — in vitro. Food Chem Toxicol. https://pubmed.ncbi.nlm.nih.gov/29287791/
14. Sánchez de Medina, F., et al. (1994). Hypoglycemic activity of juniper “berries” — animal model. Planta Med. https://pubmed.ncbi.nlm.nih.gov/8073081/
15. Cioancă, O., Hancianu, M., Mihasan, M., Hritcu, L. (2016). Anti-acetylcholinesterase and antioxidant activities of inhaled juniper oil on amyloid beta (1-42)-induced oxidative stress in the rat hippocampus — animal model. Neurochem Res. https://pubmed.ncbi.nlm.nih.gov/25743585/
16. Akkol, E. K., Güvenç, A., Yesilada, E. (2009). A comparative study on the antinociceptive and anti-inflammatory activities of five Juniperus taxa — animal model. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/19505566/
17. Janků, I., Hava, M., Motl, O. (1957). Diuretic substance from juniper (Juniperus communis L.). Experientia. https://pubmed.ncbi.nlm.nih.gov/13447954/
18. Raina, R., et al. (2019). Potential of Juniperus communis L as a nutraceutical in human and veterinary medicine — review. Heliyon. https://pubmed.ncbi.nlm.nih.gov/31508527/
19. Gonçalves, A. C., et al. (2022). Zimbro (Juniperus communis L.) as a promising source of bioactive compounds and biomedical activities — review. Int J Mol Sci. https://pubmed.ncbi.nlm.nih.gov/35328621/
20. CIR Expert Panel. (2001). Final report on the safety assessment of Juniperus communis extract, J. oxycedrus extract/tar, J. phoenicea extract, and J. virginiana extract — safety review. Int J Toxicol. https://pubmed.ncbi.nlm.nih.gov/11558640/
21. Battaglia, S. (2003). The complete guide to aromatherapy (2nd ed.). Brisbane, Australia: International Centre of Holistic Aromatherapy.
22. British Herbal Medicine Association. (1983). British Herbal Pharmacopoeia. Bournemouth, UK: Author.
23. Damjanović, B. M., Skala, D., Petrović-Djakov, D., & Baras, J. (2003). A comparison between the oil, hexane extract and supercritical carbon dioxide extract of Juniperus communis L. Journal of Essential Oil Research, 15(2), 90–92. https://doi.org/10.1080/10412905.2003.9712076